Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

New Aventis compounds block Kv1.5 potassium channels

Feb. 19, 2001

MicroHeart obtains exclusive license to angiogenic/antiinflammatory compound

Feb. 19, 2001

Novel alpha1B-adrenoceptor antagonists from Toray particularly useful in hypertension

Feb. 15, 2001

New benzimidazoles useful for atherosclerosis Rx designed at Japanese lab

Feb. 15, 2001

ApoA-I Milano shows activity in mouse model of atherosclerotic disease

Feb. 15, 2001

Independent cardiovascular study with Dusa's Levulan begins

Feb. 14, 2001

Adenosine derivatives from CV Therapeutics useful in treatment, diagnosis of CAD

Feb. 13, 2001

Former SmithKline Beecham provides macrophage scavenger receptor antagonists

Feb. 9, 2001

Benzamide vasopressin antagonists in the Fujisawa pipeline

Feb. 8, 2001

Nonpeptide IL-2 production inhibitors and their use reported by Shionogi

Feb. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...